Patrizi, Annarita <br/><br/>
Chronic Administration of the N-Methyl-D-Aspartate Receptor Antagonist Ketamine Improves Rett Syndrome Phenotype.  [electronic resource] 

 -  Biological psychiatry  May 2016 
 - 755-764 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2402 
<br/><br/><label>Standard No.: </label>10.1016/j.biopsych.2015.08.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Disease Models, Animal<br/>GABAergic Neurons--drug effects<br/>Ketamine--administration & dosage<br/>Methyl-CpG-Binding Protein 2--genetics<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Neurons--drug effects<br/>Parvalbumins--metabolism<br/>Phenotype<br/>Photic Stimulation<br/>Pyramidal Cells--drug effects<br/>Receptors, N-Methyl-D-Aspartate--antagonists & inhibitors<br/>Respiration--drug effects<br/>Rett Syndrome--drug therapy<br/>Survival Analysis<br/>Visual Acuity--drug effects<br/>Visual Cortex--drug effects